SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001731122-23-000575
Filing Date
2023-04-04
Accepted
2023-04-04 16:36:27
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A e4571_defa14a.htm DEFA14A 8757
2 GRAPHIC img_001.jpg GRAPHIC 2735216
3 GRAPHIC img_002.jpg GRAPHIC 1726823
  Complete submission text file 0001731122-23-000575.txt   6154581
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-37606 | Film No.: 23798425
SIC: 2836 Biological Products, (No Diagnostic Substances)